Oxford, United Kingdom

Raymond A Dwek

This inventor holds 62 USPTO granted patents and 17 published patent applications, plus 8 CIPO patents and 11 EPO patents, primarily in Glycosylation Research (CPC class A61K). Top assignees: Monsanto Company, Oxford University Innovation Ltd, United Therapeutics Corporation. Active years: 1987-2024.

USPTO Granted Patents = 62 

% Patents Active = 71.0

 

 

Average Co-Inventor Count = 3.8

ph-index = 20

Forward Citations = 924(Granted Patents)

Forward Citations (Not Self Cited) = 799(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Oxford,, GB (1995)
  • North Hinskey, GB (2002)
  • Oxford OX1 3QU, GB (2004)
  • North Hinksey, GB (2009)
  • Oxfordshire, GB (2002 - 2015)
  • Oxford, GB (1987 - 2022)

Company Filing History:


Years Active: 1987-2024

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Glycosylation Markers
Iminosugars
Viral Diseases
Hepatic Fibrosis
Biomarkers
Piperidine Derivatives
Glycolipid Storage
Cancer Diagnosis
Hepatitis Treatment
Combination Therapy
Liposomes
Physiological Markers
62 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, created for idiyas.com, I will provide you with the requested article about inventor Raymond A Dwek.

Title: Raymond A Dwek - Pioneering Innovations in Medicine

Introduction:

Raymond A Dwek, a prominent inventor based in Oxford, GB, has made significant contributions to the field of medicine with over 61 patents to his name. His groundbreaking work has focused on areas such as clinical diagnosis and treatment of diseases using innovative biomarkers and therapeutic methods.

Latest Patents:

One of Raymond A Dwek's latest patents includes a revolutionary method for the clinical diagnosis of non-alcoholic fatty liver disease (NAFLD) using a panel of human blood protein biomarkers. This invention not only enables accurate diagnosis and staging of NAFLD but also provides insights into prognosing and monitoring the progression of the disease. Additionally, his work on iminosugars and their role in treating viral infections, particularly those associated with Dengue virus, showcases his commitment to advancing medical treatments.

Career Highlights:

Throughout his career, Raymond A Dwek has held key positions at renowned companies such as Monsanto Company and The Chancellor, Masters and Scholars of the University of Oxford. His expertise and dedication have been instrumental in developing cutting-edge solutions for pressing medical challenges.

Collaborations:

Raymond A Dwek has collaborated closely with esteemed coworkers, including Terry D Butters and Thomas William Rademacher, in his research endeavors. Together, they have achieved remarkable breakthroughs in the field of medicine, pushing the boundaries of innovation and knowledge.

Conclusion:

In conclusion, Raymond A Dwek stands out as a visionary inventor whose pioneering work in medicine has transformed the landscape of healthcare. His patents and collaborations reflect his unwavering commitment to advancing diagnostic tools and treatment modalities, ultimately improving patient outcomes and quality of life.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…